Published in J Clin Microbiol on November 01, 1992
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer (2003) 8.01
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol (1997) 5.76
A sensitive, type-specific, fluorogenic probe assay for detection of human papillomavirus DNA. J Clin Microbiol (1997) 2.46
Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol (2002) 2.18
Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol (1996) 2.03
International proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus DNA: evaluation of accuracy and intralaboratory and interlaboratory agreement. J Clin Microbiol (2003) 1.23
Detection of human papillomavirus DNA in cervical lavage specimens by a nonisotopic consensus PCR assay. J Clin Microbiol (1995) 1.17
Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format. J Clin Microbiol (2001) 1.05
Comparison of real-time PCR signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in archival cervical cancer tissue. J Clin Microbiol (2004) 1.03
Epidemiological evidence of cervical intraepithelial neoplasia without the presence of human papillomavirus. Br J Cancer (1996) 0.98
Anal human papillomavirus and anal cancer. J Clin Pathol (1997) 0.97
Socioeconomic differences in cervical cancer: two case-control studies in Colombia and Spain. Am J Public Health (1996) 0.87
Comparison of ViraPap, southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol (1995) 0.86
Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA. J Clin Microbiol (1996) 0.82
Absence of human papillomavirus sequences in ovarian pathologies. J Clin Microbiol (1995) 0.79
Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins. J Clin Microbiol (1994) 0.77
Human papillomaviruses in hypopharyngeal squamous cell carcinoma. Indian J Otolaryngol Head Neck Surg (1998) 0.75
Effect of nonionic detergents on amplification of human papillomavirus DNA with consensus primers MY09 and MY11. J Clin Microbiol (1998) 0.75
Avoiding false positives with PCR. Nature (1989) 30.66
Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA (1991) 6.83
Human papillomaviruses in the pathogenesis of anogenital cancer. Virology (1991) 5.74
Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst (1990) 3.98
Epidemiology of genital human papillomavirus infection. Epidemiol Rev (1988) 3.32
Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol (1991) 3.10
General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int J Cancer (1990) 2.69
Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer (1991) 2.19
Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol (1991) 2.19
Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med (1989) 1.94
The sexually transmitted disease model for cervical cancer: incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection. Epidemiology (1991) 1.89
Identification of human papillomavirus in cervical swabs by deoxyribonucleic acid in situ hybridization. Obstet Gynecol (1984) 1.80
Amplification of human papillomavirus DNA sequences by using conserved primers. J Clin Microbiol (1989) 1.80
Does human papillomavirus cause cervical cancer? The state of the epidemiological evidence. Br J Cancer (1988) 1.74
A direct comparison of methods proposed for use in widespread screening of human papillomavirus infections. Mol Cell Probes (1991) 1.34
Uric acid as an inhibitor of cyclophosphamide-induced micronuclei in mice. Mutat Res (1991) 1.28
Inter-laboratory variation as an explanation for varying prevalence estimates of human papillomavirus infection. Int J Cancer (1989) 1.27
Comparative analysis of human papillomavirus detection by polymerase chain reaction and Virapap/Viratype kits. Am J Clin Pathol (1990) 1.16
Comparison of Southern transfer hybridization and dot filter hybridization for detection of cervical human papillomavirus infection with types 6, 11, 16, 18, 31, 33, and 35. Am J Clin Pathol (1990) 1.08
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer (2003) 8.01
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Worldwide burden of cervical cancer in 2008. Ann Oncol (2011) 5.66
The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer (1992) 3.88
Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin (2001) 3.65
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer. Oncogene (2011) 3.59
The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. Virology (1979) 3.25
Risk factors for cervical cancer in Colombia and Spain. Int J Cancer (1992) 2.75
Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer (1994) 2.74
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis (1973) 2.40
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol (1997) 2.40
Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev (1997) 2.36
Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer (2004) 2.33
Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer (1994) 2.23
Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer (2001) 2.22
Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst (1998) 2.19
Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage. Virology (1981) 2.13
Genetic resource impacts of habitat loss and degradation; reconciling empirical evidence and predicted theory for neotropical trees. Heredity (Edinb) (2005) 2.11
Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol (2000) 2.06
Neurological assessment of high grade astrocytomas following high dose radiotherapy as sole treatment. Clin Oncol (R Coll Radiol) (1995) 2.04
Vascular endothelial growth factor and hypertrophic osteoarthropathy. Clin Exp Rheumatol (2000) 2.03
[Factors associated with the accumulation of abdominal fat estimated with anthropometric indexes]. Med Clin (Barc) (2000) 2.02
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age. Br J Cancer (2011) 1.96
Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst (1996) 1.96
Nasopharyngeal carcinoma. X. Presence of epstein-barr genomes in separated epithelial cells of tumours in patients from Singapore, Tunisia and Kenya. Int J Cancer (1975) 1.95
Rescue of the albino phenotype by introduction of a functional tyrosinase gene into mice. EMBO J (1990) 1.91
Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer (1999) 1.91
Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res (2001) 1.85
Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer (2002) 1.83
International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer (2000) 1.79
Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol (2009) 1.77
Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer (2001) 1.75
Histologic types of gastric carcinoma in high- and low-risk areas. Int J Cancer (1968) 1.73
The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer (1998) 1.69
Human papillomavirus genotypes in rural Mozambique. Lancet (2001) 1.69
Sarcoma in a hamster inoculated with BK virus, a human papovavirus. J Natl Cancer Inst (1975) 1.65
Intratype variation in 12 human papillomavirus types: a worldwide perspective. J Virol (1996) 1.65
Major histocompatibility complex and tumor necrosis factor-alpha polymorphisms in pigeon breeder's disease. Am J Respir Crit Care Med (2001) 1.64
Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res (1998) 1.63
Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol (1998) 1.63
Pressure support ventilation in patients with acute lung injury. Crit Care Med (2000) 1.63
The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer (1996) 1.61
Weight change in later life and risk of death amongst the elderly: the European Prospective Investigation into Cancer and Nutrition-Elderly Network on Ageing and Health study. J Intern Med (2010) 1.58
Cervical cancer. Cancer Surv (1994) 1.57
International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer (1998) 1.56
Penetrating colon injuries requiring resection: diversion or primary anastomosis? An AAST prospective multicenter study. J Trauma (2001) 1.56
Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis (1997) 1.56
Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev (1993) 1.56
Combined analysis of matched and unmatched case-control studies: comparison of risk estimates from different studies. Am J Epidemiol (1996) 1.55
Consumption of vegetables, fruit and other plant foods in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts from 10 European countries. Public Health Nutr (2002) 1.53
Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst (1998) 1.53
Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round. Int J Cancer (1997) 1.52
Molecular characterization and expression of the stratification-related cytokeratins 4 and 15. J Cell Biol (1988) 1.50
Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res (1999) 1.50
Increased rectal cell proliferation following alcohol abuse. Gut (2001) 1.49
Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol (1995) 1.48
Human papillomavirus testing for primary screening in women at low risk of developing cervical cancer. The Greek experience. Gynecol Oncol (2005) 1.47
Gastroprotective effect of zinc acexamate against damage induced by nonsteroidal antiinflammatory drugs. A morphological study. Dig Dis Sci (1993) 1.46
Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis. Eur J Clin Nutr (2012) 1.46